pertuzumab,trastuzumab
medsir,roche
['perelisa', 'medsir']
a correlative analysis from the perelisa trial show that her2dx could help tailor systemic therapy since it predicts et sensitivity and pcr after neoadj t+p+et in pts with early-stage her2+/hr+ bc. #valentinaguarneri #esmo22 
Bring your idea to life??Creating successful IITs & optimal drug development??Medica Scientia Innovation Research????????https://t.co/cciUf0lqpM